Credo Technology Group reports fiscal Q1 results today with the stock trading at a demanding premium — and short sellers have been methodically adding exposure through August.
Short interest has climbed roughly 16% over the past month to 3.6% of the free float, with the bulk of that move concentrated in the final two weeks of August. That pace of accumulation is worth watching even if the absolute level is modest. The lending market offers no amplification: borrow is essentially free at 0.21%, and availability is effectively uncapped, meaning new shorts face no squeeze pressure whatsoever. Options positioning is close to neutral — the put/call ratio of 0.93 is barely above its 20-day average of 0.92, a z-score of just 0.34. Neither the options market nor the borrow market is flashing alarm; what's notable is simply that more shares have been sold short into a stock that has rallied over 9% in the past month to $226.19.
The fundamental debate is sharp. Bulls point to Credo's differentiated position in high-speed data-centre connectivity, an optical portfolio that analysts see driving potential revenue growth of over 80% in fiscal 2027, and a string of upward analyst revisions. TD Cowen lifted its target to $300 in August, and BofA Securities pushed to $340 after the prior quarter — well above the current price. The consensus mean target of $283 implies roughly 25% upside from here. Bears counter that the valuation already prices much of the optimism in: the stock trades at nearly 30x trailing earnings and over 10x book value, both multiples that have expanded sharply over the past month. Revenue growth is also expected to be front-loaded toward the second half of the year, leaving nearer-term quarters more exposed to disappointment. Rosenblatt is an outlier, holding a Neutral rating with a $215 target — below the current price.
The historical earnings pattern adds context. The two most recent quarterly prints both produced negative first-day reactions of roughly 3–5%, though the one-day move on the June 2026 print was followed by a partial recovery over five days. Peer performance on Monday offered a cautious backdrop: ENTG, FORM, and SMTC all fell 7–8% on the session, while CRDO declined a more contained 2.8%, suggesting the stock retains relative strength even in a broader semiconductor selloff.
Tonight's print will test whether Credo's optical ramp is materialising early enough to justify a multiple that leaves almost no margin for execution shortfalls.
See the live data behind this article on ORTEX.
Open CRDO on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
